PTK2 and neoplasm: Of importance, the combination of 3289-8625 and VS-6063 was not more toxic in non-transformed mesothelial cells than the approved drug Cis-Pt, indicating that blocking FAK and Wnt signaling pathways more strongly affected tumor cells than untransformed (normal) mesothelial cells.